Current Data

U.S. Cannabis Spot Index up 1.1% to $1,389 per pound.

The simple average (non-volume weighted) price increased $4 to $1,600 per pound, with 68% of transactions (one standard deviation) in the $854 to $2,347 per pound range. The average reported deal size declined to 2.1 pounds. In grams, the Spot price was $3.06 and the simple average price was $3.53.

The relative frequency of trades for outdoor flower increased by 1% this week. The relative frequency of transactions involving indoor product decreased by the same proportion, while that for greenhouse flower was stable. Greenhouse product’s share of the total documented weight moved nationally contracted by almost 3% this week. The relative volumes of warehouse and outdoor flower grew by about 2% and 1%, respectively.

The U.S. Spot Index rose by 1.1% this week to settle at $1,389 per pound. Upticks in the weekly composite prices of Colorado, Oregon, Washington, and Nevada, as well as the mid-sized markets of Michigan, Massachusetts, and Illinois, outweighed declines in California and Arizona.  

The opening half of September has seen the U.S. Spot level off a bit just below its current annual peak of $1,404 per pound, documented in the final week of August. While the behavior of wholesale cannabis prices in the weeks ahead depend largely on the fall harvest, it must be noted that available historical sales data from both adult-use and medical markets indicates that demand tends to subside in the period from September through November. Still, as we point out in regard to Colorado, lower demand in the coming months could still be stronger relative to that observed in the same period in recent years.

The national volume-weighted price for flower to be sold to general consumers jumped this week as nearly every market in which adult-use sales are taking place saw rates for such product increase, with Alaska the only exception. Prices for medical flower slipped again this week, primarily on decreases in that sector of the market in California, as well as in Arizona, New Mexico, Rhode Island, and some other smaller medical-only markets.